Filaggrinopathies-FLG/FLG2: Diagnostic Complexities and Immunotherapy

Area of Science:

• Dermatology
• Genetics
• Immunology

Background:

• Filaggrin (FLG) and Filaggrin-2 (FLG2) proteins are essential for epidermal differentiation and skin barrier integrity.
• Dysfunction of FLG and FLG2 leads to filaggrinopathies, presenting a range of genetic and multifactorial conditions.

Purpose of the Study:

• To review the biosynthesis and function of FLG and FLG2 proteins.
• To evaluate the molecular pathogenesis of filaggrinopathies.
• To assess genotype-phenotype correlations and immune dysregulation patterns.

Main Methods:

• Literature review of FLG and FLG2 protein function.
• Analysis of molecular pathogenesis in filaggrinopathies.
• Examination of genotype-phenotype correlations and immune dysregulation.
• Review of current immunotherapeutic strategies targeting cytokines.

Main Results:

• FLG and FLG2 are vital for skin barrier formation.
• Filaggrinopathies exhibit diverse phenotypes and genetic complexities.
• Immune dysregulation is a common feature in filaggrinopathies.
• Targeting cytokines shows promise for filaggrinopathy treatment.

Conclusions:

• Understanding FLG and FLG2 is key to managing filaggrinopathies.
• Accurate genetic diagnosis and understanding immune patterns are critical.
• Cytokine-targeted immunotherapies offer potential therapeutic avenues.